Published in Gastroenterology on September 07, 2013
Fecal Microbiota Transplantation for Pancreatitis (FMTP) | NCT02318134
Clinical Trial of Gut Microbiota in the Management of Immune Thrombocytopenia | NCT03033199
Fecal Microbiota Transplantation (FMT) in Multiple Sclerosis | NCT03975413
The microbiome in inflammatory bowel disease: current status and the future ahead. Gastroenterology (2014) 2.73
Inflammatory bowel disease as a model for translating the microbiome. Immunity (2014) 1.39
From stool transplants to next-generation microbiota therapeutics. Gastroenterology (2014) 1.29
Intestinal microbiota in health and disease: role of bifidobacteria in gut homeostasis. World J Gastroenterol (2014) 1.19
Manipulating the gut microbiota to maintain health and treat disease. Microb Ecol Health Dis (2015) 1.09
Irritable bowel syndrome: a microbiome-gut-brain axis disorder? World J Gastroenterol (2014) 1.06
Clostridium difficile and inflammatory bowel disease: role in pathogenesis and implications in treatment. World J Gastroenterol (2013) 1.03
Current status and prospects of intestinal microbiome studies. Intest Res (2014) 1.02
Faecal microbiota transplantation: applications and limitations in treating gastrointestinal disorders. BMJ Open Gastroenterol (2016) 1.02
Treatment of IBD: where we are and where we are going. Am J Gastroenterol (2014) 1.02
Understanding the mechanisms of faecal microbiota transplantation. Nat Rev Gastroenterol Hepatol (2016) 1.01
Characterization of the 17 strains of regulatory T cell-inducing human-derived Clostridia. Gut Microbes (2014) 1.00
Role of the enteric microbiota in intestinal homeostasis and inflammation. Free Radic Biol Med (2013) 0.98
Gut-liver axis and probiotics: their role in non-alcoholic fatty liver disease. World J Gastroenterol (2014) 0.96
Fecal microbiota transplantation: effectiveness, complexities, and lingering concerns. Mucosal Immunol (2014) 0.95
Intestinal microbiota and faecal transplantation as treatment modality for insulin resistance and type 2 diabetes mellitus. Clin Exp Immunol (2014) 0.92
Nutrition facts in multiple sclerosis. ASN Neuro (2015) 0.91
Fecal Microbiota Transplantation: Current Applications, Effectiveness, and Future Perspectives. Clin Endosc (2016) 0.90
Gut microbiome and anticancer immune response: really hot Sh*t! Cell Death Differ (2014) 0.90
Intestinal microbial variation may predict early acute rejection after liver transplantation in rats. Transplantation (2014) 0.89
Fecal microbiota transplantation and bacterial consortium transplantation have comparable effects on the re-establishment of mucosal barrier function in mice with intestinal dysbiosis. Front Microbiol (2015) 0.89
Fecal microbiota transplantation in inflammatory bowel disease: beyond the excitement. Medicine (Baltimore) (2014) 0.89
Cross-fostering immediately after birth induces a permanent microbiota shift that is shaped by the nursing mother. Microbiome (2015) 0.88
Effect of probiotic administration on the intestinal microbiota, current knowledge and potential applications. World J Gastroenterol (2014) 0.88
Intestinal dysbiosis in children with short bowel syndrome is associated with impaired outcome. Microbiome (2015) 0.86
Probiotics and necrotizing enterocolitis. Clin Perinatol (2014) 0.86
Enteric microbiota leads to new therapeutic strategies for ulcerative colitis. World J Gastroenterol (2014) 0.85
The microbiome: what it means for medicine. Br J Gen Pract (2014) 0.85
Diet, microbiota, and inflammatory bowel disease: lessons from Japanese foods. Korean J Intern Med (2014) 0.83
Pathway-based approaches to the treatment of inflammatory bowel disease. Transl Res (2015) 0.83
Fecal transplantation treatment of antibiotic-induced, noninfectious colitis and long-term microbiota follow-up. Case Rep Med (2014) 0.83
Fecal microbiota transplantation: in perspective. Therap Adv Gastroenterol (2016) 0.82
Fecal Microbiota Transplantation Improves the Quality of Life in Patients with Inflammatory Bowel Disease. Gastroenterol Res Pract (2015) 0.82
Intestinal microbiome landscaping: insight in community assemblage and implications for microbial modulation strategies. FEMS Microbiol Rev (2017) 0.80
Rural and urban microbiota: To be or not to be? Gut Microbes (2014) 0.80
The Gut-Brain Axis: The Missing Link in Depression. Clin Psychopharmacol Neurosci (2015) 0.80
Fecal transplant policy and legislation. World J Gastroenterol (2015) 0.80
16S gut community of the Cameron County Hispanic Cohort. Microbiome (2015) 0.79
Indole compounds may be promising medicines for ulcerative colitis. J Gastroenterol (2016) 0.78
Prospects for therapeutic tolerance in humans. Curr Opin Rheumatol (2014) 0.78
Toward the comprehensive understanding of the gut ecosystem via metabolomics-based integrated omics approach. Semin Immunopathol (2014) 0.78
Fecal microbiota transplantation: current clinical efficacy and future prospects. Clin Exp Gastroenterol (2015) 0.77
Mucosal Immune Development in Early Life: Setting the Stage. Arch Immunol Ther Exp (Warsz) (2015) 0.77
Proteins and Carbohydrates from Red Seaweeds: Evidence for Beneficial Effects on Gut Function and Microbiota. Mar Drugs (2015) 0.77
Fecal Microbiota Transplantation: A Review of Emerging Indications Beyond Relapsing Clostridium difficile Toxin Colitis. Gastroenterol Hepatol (N Y) (2015) 0.77
Can attention to the intestinal microbiota improve understanding and treatment of anorexia nervosa? Expert Rev Gastroenterol Hepatol (2016) 0.77
Treatment and management of Chronic Fatigue Syndrome/Myalgic Encephalomyelitis: all roads lead to Rome. Br J Pharmacol (2017) 0.77
Fecal Microbiota Transplantation and Its Usage in Neuropsychiatric Disorders. Clin Psychopharmacol Neurosci (2016) 0.76
The New Era of Treatment for Obesity and Metabolic Disorders: Evidence and Expectations for Gut Microbiome Transplantation. Front Cell Infect Microbiol (2016) 0.76
Involvement of Reduced Microbial Diversity in Inflammatory Bowel Disease. Gastroenterol Res Pract (2016) 0.76
Gut Microbiota in Obesity and Undernutrition. Adv Nutr (2016) 0.76
The art of targeting gut microbiota for tackling human obesity. Genes Nutr (2015) 0.76
The importance of appropriate initial bacterial colonization of the intestine in newborn, child and adult health. Pediatr Res (2017) 0.76
Fecal microbiota transplantation in metabolic syndrome: History, present and future. Gut Microbes (2017) 0.75
A psychology of the human brain-gut-microbiome axis. Soc Personal Psychol Compass (2017) 0.75
Complicated fecal microbiota transplantation in a tetraplegic patient with severe Clostridium difficile infection. World J Gastroenterol (2015) 0.75
Fecal microbiota transplantation for severe clostridium difficile infection after left ventricular assist device implantation: a case control study and concise review on the local and regional therapies. BMC Infect Dis (2016) 0.75
The personal touch: strategies toward personalized vaccines and predicting immune responses to them. Expert Rev Vaccines (2014) 0.75
Editorial on "Cancer and the microbiota" published in Science. Ann Transl Med (2015) 0.75
Evaluation of Fecal Microbiota Transfer as Treatment for Postweaning Diarrhea in Research-Colony Puppies. J Am Assoc Lab Anim Sci (2016) 0.75
Fecal Microbiota Transplantation: Expanding Horizons for Clostridium difficile Infections and Beyond. Antibiotics (Basel) (2015) 0.75
Probiotics research in Galleria mellonella. Virulence (2015) 0.75
CT-guided versus laparoscopic radiofrequency ablation in recurrent small hepatocellular carcinoma against the diaphragmatic dome. Sci Rep (2017) 0.75
Novel prevention strategies for bacterial infections in cirrhosis. Expert Opin Pharmacother (2016) 0.75
THE POWER OF POOP: FECAL MICROBIOTA TRANSPLANTATION FOR CLOSTRIDIUM DIFFICILE INFECTION. Trans Am Clin Climatol Assoc (2016) 0.75
Eggshell membrane powder ameliorates intestinal inflammation by facilitating the restitution of epithelial injury and alleviating microbial dysbiosis. Sci Rep (2017) 0.75
Profiling Living Bacteria Informs Preparation of Fecal Microbiota Transplantations. PLoS One (2017) 0.75
A survey using the social networks revealed poor knowledge on fecal microbiota transplantation. J Neurogastroenterol Motil (2015) 0.75
Chinese physicians' perceptions of fecal microbiota transplantation. World J Gastroenterol (2016) 0.75
The Eukaryotic Microbiome: Origins and Implications for Fetal and Neonatal Life. Front Pediatr (2016) 0.75
Fructo-oligosaccharides and intestinal barrier function in a methionine-choline-deficient mouse model of nonalcoholic steatohepatitis. PLoS One (2017) 0.75
The possible mechanisms of the human microbiome in allergic diseases. Eur Arch Otorhinolaryngol (2016) 0.75
An Integrated Outlook on the Metagenome and Metabolome of Intestinal Diseases. Diseases (2015) 0.75
Enterotypes of the human gut microbiome. Nature (2011) 24.36
Duodenal infusion of donor feces for recurrent Clostridium difficile. N Engl J Med (2013) 20.65
Complete genome sequence of Lactobacillus plantarum WCFS1. Proc Natl Acad Sci U S A (2003) 8.40
Richness of human gut microbiome correlates with metabolic markers. Nature (2013) 6.93
Mucosa-associated bacteria in the human gastrointestinal tract are uniformly distributed along the colon and differ from the community recovered from feces. Appl Environ Microbiol (2002) 6.74
Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome. Gastroenterology (2012) 6.04
Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proc Natl Acad Sci U S A (2013) 5.88
Comparative analysis of pyrosequencing and a phylogenetic microarray for exploring microbial community structures in the human distal intestine. PLoS One (2009) 4.93
CRISPR immunity relies on the consecutive binding and degradation of negatively supercoiled invader DNA by Cascade and Cas3. Mol Cell (2012) 4.84
Comparative genomic analysis of Lactobacillus rhamnosus GG reveals pili containing a human- mucus binding protein. Proc Natl Acad Sci U S A (2009) 4.61
Akkermansia muciniphila gen. nov., sp. nov., a human intestinal mucin-degrading bacterium. Int J Syst Evol Microbiol (2004) 4.05
Comparative analysis of fecal DNA extraction methods with phylogenetic microarray: effective recovery of bacterial and archaeal DNA using mechanical cell lysis. J Microbiol Methods (2010) 3.58
Development and application of the human intestinal tract chip, a phylogenetic microarray: analysis of universally conserved phylotypes in the abundant microbiota of young and elderly adults. Environ Microbiol (2009) 3.57
Molecular diversity of Lactobacillus spp. and other lactic acid bacteria in the human intestine as determined by specific amplification of 16S ribosomal DNA. Appl Environ Microbiol (2002) 3.43
Insight into the prebiotic concept: lessons from an exploratory, double blind intervention study with inulin-type fructans in obese women. Gut (2012) 3.09
Diversity of the human gastrointestinal tract microbiota revisited. Environ Microbiol (2007) 3.00
Colonic microbiota signatures across five northern European countries. Appl Environ Microbiol (2005) 2.98
Global and deep molecular analysis of microbiota signatures in fecal samples from patients with irritable bowel syndrome. Gastroenterology (2011) 2.79
A microbial world within us. Mol Microbiol (2006) 2.76
S layer protein A of Lactobacillus acidophilus NCFM regulates immature dendritic cell and T cell functions. Proc Natl Acad Sci U S A (2008) 2.65
Anaerobic microbial dehalogenation. Annu Rev Microbiol (2004) 2.51
Metagenomic species profiling using universal phylogenetic marker genes. Nat Methods (2013) 2.51
Responses of gut microbiota and glucose and lipid metabolism to prebiotics in genetic obese and diet-induced leptin-resistant mice. Diabetes (2011) 2.46
Differential NF-kappaB pathways induction by Lactobacillus plantarum in the duodenum of healthy humans correlating with immune tolerance. Proc Natl Acad Sci U S A (2009) 2.29
Functional genome analysis of Bifidobacterium breve UCC2003 reveals type IVb tight adherence (Tad) pili as an essential and conserved host-colonization factor. Proc Natl Acad Sci U S A (2011) 2.22
Analysis of growth of Lactobacillus plantarum WCFS1 on a complex medium using a genome-scale metabolic model. J Biol Chem (2006) 2.17
The Lrp family of transcriptional regulators. Mol Microbiol (2003) 2.15
The Mucin degrader Akkermansia muciniphila is an abundant resident of the human intestinal tract. Appl Environ Microbiol (2007) 2.09
Identification of Lactobacillus plantarum genes that are induced in the gastrointestinal tract of mice. J Bacteriol (2004) 2.06
Exploring Lactobacillus plantarum genome diversity by using microarrays. J Bacteriol (2005) 2.02
The micro-Petri dish, a million-well growth chip for the culture and high-throughput screening of microorganisms. Proc Natl Acad Sci U S A (2007) 1.94
The genome of Akkermansia muciniphila, a dedicated intestinal mucin degrader, and its use in exploring intestinal metagenomes. PLoS One (2011) 1.90
Probiotic and other functional microbes: from markets to mechanisms. Curr Opin Biotechnol (2005) 1.89
Intestinal microbiota in healthy adults: temporal analysis reveals individual and common core and relation to intestinal symptoms. PLoS One (2011) 1.88
Hydrogenomics of the extremely thermophilic bacterium Caldicellulosiruptor saccharolyticus. Appl Environ Microbiol (2008) 1.85
Biodiversity-based identification and functional characterization of the mannose-specific adhesin of Lactobacillus plantarum. J Bacteriol (2005) 1.85
Quantification of uncultured Ruminococcus obeum-like bacteria in human fecal samples by fluorescent in situ hybridization and flow cytometry using 16S rRNA-targeted probes. Appl Environ Microbiol (2002) 1.82
The human small intestinal microbiota is driven by rapid uptake and conversion of simple carbohydrates. ISME J (2012) 1.81
Microbes inside--from diversity to function: the case of Akkermansia. ISME J (2012) 1.80
Development of bacterial and bifidobacterial communities in feces of newborn babies. Anaerobe (2003) 1.78
Microarray analysis and barcoded pyrosequencing provide consistent microbial profiles depending on the source of human intestinal samples. Appl Environ Microbiol (2011) 1.76
Isolation of RNA from bacterial samples of the human gastrointestinal tract. Nat Protoc (2006) 1.75
Genetic diversity of viable, injured, and dead fecal bacteria assessed by fluorescence-activated cell sorting and 16S rRNA gene analysis. Appl Environ Microbiol (2005) 1.74
Intestinal integrity and Akkermansia muciniphila, a mucin-degrading member of the intestinal microbiota present in infants, adults, and the elderly. Appl Environ Microbiol (2007) 1.73
Mucosal adhesion properties of the probiotic Lactobacillus rhamnosus GG SpaCBA and SpaFED pilin subunits. Appl Environ Microbiol (2010) 1.71
Modulation of Mucosal Immune Response, Tolerance, and Proliferation in Mice Colonized by the Mucin-Degrader Akkermansia muciniphila. Front Microbiol (2011) 1.69
Complete sequences of four plasmids of Lactococcus lactis subsp. cremoris SK11 reveal extensive adaptation to the dairy environment. Appl Environ Microbiol (2005) 1.69
Mucin-bacterial interactions in the human oral cavity and digestive tract. Gut Microbes (2010) 1.65
Intestinal microbiota in human health and disease: the impact of probiotics. Genes Nutr (2011) 1.63
Phylogenetic analysis of dysbiosis in ulcerative colitis during remission. Inflamm Bowel Dis (2013) 1.63
An agr-like two-component regulatory system in Lactobacillus plantarum is involved in production of a novel cyclic peptide and regulation of adherence. J Bacteriol (2005) 1.61
Cell to cell communication by autoinducing peptides in gram-positive bacteria. Antonie Van Leeuwenhoek (2002) 1.61
Comparative genomics of Lactobacillus. Microb Biotechnol (2010) 1.60
The intestinal LABs. Antonie Van Leeuwenhoek (2002) 1.60
The function of our microbiota: who is out there and what do they do? Front Cell Infect Microbiol (2012) 1.54
Gastrointestinal microbiota in irritable bowel syndrome: present state and perspectives. Microbiology (2010) 1.50
Identification of prebiotic fructooligosaccharide metabolism in Lactobacillus plantarum WCFS1 through microarrays. Appl Environ Microbiol (2007) 1.48
Diversity, dynamics, and activity of bacterial communities during production of an artisanal Sicilian cheese as evaluated by 16S rRNA analysis. Appl Environ Microbiol (2002) 1.48
Altered gut microbiota and endocannabinoid system tone in obese and diabetic leptin-resistant mice: impact on apelin regulation in adipose tissue. Front Microbiol (2011) 1.46
Isolation of DNA from bacterial samples of the human gastrointestinal tract. Nat Protoc (2006) 1.43
Linking phylogenetic identities of bacteria to starch fermentation in an in vitro model of the large intestine by RNA-based stable isotope probing. Environ Microbiol (2008) 1.40
Characterization of the SpaCBA pilus fibers in the probiotic Lactobacillus rhamnosus GG. Appl Environ Microbiol (2012) 1.39
Increased production of folate by metabolic engineering of Lactococcus lactis. Appl Environ Microbiol (2003) 1.37
Description of Sulfurospirillum halorespirans sp. nov., an anaerobic, tetrachloroethene-respiring bacterium, and transfer of Dehalospirillum multivorans to the genus Sulfurospirillum as Sulfurospirillum multivorans comb. nov. Int J Syst Evol Microbiol (2003) 1.36
Metaproteomics approach to study the functionality of the microbiota in the human infant gastrointestinal tract. Appl Environ Microbiol (2006) 1.36
Genetic characterization of the bile salt response in Lactobacillus plantarum and analysis of responsive promoters in vitro and in situ in the gastrointestinal tract. J Bacteriol (2004) 1.36
Mixed-species genomic microarray analysis of fecal samples reveals differential transcriptional responses of bifidobacteria in breast- and formula-fed infants. Appl Environ Microbiol (2009) 1.35
The first 1000 cultured species of the human gastrointestinal microbiota. FEMS Microbiol Rev (2014) 1.34
Microbiota conservation and BMI signatures in adult monozygotic twins. ISME J (2012) 1.34
Convergence in probiotic Lactobacillus gut-adaptive responses in humans and mice. ISME J (2010) 1.33
Spatial and temporal expression of Lactobacillus plantarum genes in the gastrointestinal tracts of mice. Appl Environ Microbiol (2006) 1.31
The complete genomes of Lactobacillus plantarum and Lactobacillus johnsonii reveal extensive differences in chromosome organization and gene content. Microbiology (2004) 1.31
Characterization of germination receptors of Bacillus cereus ATCC 14579. Appl Environ Microbiol (2006) 1.31
Human intestinal microbiota composition is associated with local and systemic inflammation in obesity. Obesity (Silver Spring) (2013) 1.31
Identification and functional verification of archaeal-type phosphoenolpyruvate carboxylase, a missing link in archaeal central carbohydrate metabolism. J Bacteriol (2004) 1.30
The Sulfolobus solfataricus Lrp-like protein LysM regulates lysine biosynthesis in response to lysine availability. J Biol Chem (2002) 1.30
Comparative metaproteomics and diversity analysis of human intestinal microbiota testifies for its temporal stability and expression of core functions. PLoS One (2012) 1.28
The prophage sequences of Lactobacillus plantarum strain WCFS1. Virology (2003) 1.28
Victivallis vadensis gen. nov., sp. nov., a sugar-fermenting anaerobe from human faeces. Int J Syst Evol Microbiol (2003) 1.27
The novel porcine Lactobacillus sobrius strain protects intestinal cells from enterotoxigenic Escherichia coli K88 infection and prevents membrane barrier damage. J Nutr (2007) 1.26
Diversity, vitality and activities of intestinal lactic acid bacteria and bifidobacteria assessed by molecular approaches. FEMS Microbiol Rev (2005) 1.26
Long-term monitoring of the human intestinal microbiota composition. Environ Microbiol (2012) 1.26
An iterative workflow for mining the human intestinal metaproteome. BMC Genomics (2011) 1.25
Specific response of a novel and abundant Lactobacillus amylovorus-like phylotype to dietary prebiotics in the guts of weaning piglets. Appl Environ Microbiol (2004) 1.24
The complete coenzyme B12 biosynthesis gene cluster of Lactobacillus reuteri CRL1098. Microbiology (2008) 1.22
Beyond diversity: functional microbiomics of the human colon. Trends Microbiol (2006) 1.22
TRASH: a novel metal-binding domain predicted to be involved in heavy-metal sensing, trafficking and resistance. Trends Biochem Sci (2003) 1.21
Comparative genomic and functional analysis of 100 Lactobacillus rhamnosus strains and their comparison with strain GG. PLoS Genet (2013) 1.21
Engineering a selectable marker for hyperthermophiles. J Biol Chem (2005) 1.20
The heat-shock response of Listeria monocytogenes comprises genes involved in heat shock, cell division, cell wall synthesis, and the SOS response. Microbiology (2007) 1.19
The alternative sigma factor sigmaB of Bacillus cereus: response to stress and role in heat adaptation. J Bacteriol (2004) 1.18
Comparative genomic and functional analysis of Lactobacillus casei and Lactobacillus rhamnosus strains marketed as probiotics. Appl Environ Microbiol (2013) 1.18
Metatranscriptome analysis of the human fecal microbiota reveals subject-specific expression profiles, with genes encoding proteins involved in carbohydrate metabolism being dominantly expressed. Appl Environ Microbiol (2010) 1.18
Thioredoxin reductase is a key factor in the oxidative stress response of Lactobacillus plantarum WCFS1. Microb Cell Fact (2007) 1.17
Molecular approaches for the detection and identification of bifidobacteria and lactobacilli in the human gastrointestinal tract. Syst Appl Microbiol (2003) 1.17
gerR, a novel ger operon involved in L-alanine- and inosine-initiated germination of Bacillus cereus ATCC 14579. Appl Environ Microbiol (2005) 1.17
Growth and sporulation of Bacillus cereus ATCC 14579 under defined conditions: temporal expression of genes for key sigma factors. Appl Environ Microbiol (2004) 1.14